| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Stacey E Alexeeff, Deborah Ansley, Alyssa Vanderziel, Gwen T Lapha. Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy. Obstetrics and gynecology. 2025-03-13. PMID:40080822. |
self-reported preconception daily cannabis use was associated with greater odds of mild (adjusted odds ratio [aor] 1.68, 95% ci, 1.59-1.77) and severe (aor 2.61, 95% ci, 2.40-2.84) nvp when compared with individuals without preconception use. |
2025-03-13 |
2025-03-16 |
Not clear |
| Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Stacey E Alexeeff, Deborah Ansley, Alyssa Vanderziel, Gwen T Lapha. Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy. Obstetrics and gynecology. 2025-03-13. PMID:40080822. |
self-reported weekly cannabis use was associated with greater odds of mild (aor 1.26, 95% ci, 1.19-1.34) and severe (aor 1.73, 95% ci, 1.57-1.90) nvp compared with no preconception use. |
2025-03-13 |
2025-03-16 |
Not clear |
| Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Stacey E Alexeeff, Deborah Ansley, Alyssa Vanderziel, Gwen T Lapha. Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy. Obstetrics and gynecology. 2025-03-13. PMID:40080822. |
similarly, self-reported prenatal daily cannabis use was associated with greater odds of mild (aor 1.97, 95% ci, 1.79-2.17) and severe (aor 3.80, 95% ci, 3.28-4.39) nvp compared with no prenatal use. |
2025-03-13 |
2025-03-16 |
Not clear |
| Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Stacey E Alexeeff, Deborah Ansley, Alyssa Vanderziel, Gwen T Lapha. Frequency of Preconception and Prenatal Cannabis Use and Nausea and Vomiting in Pregnancy. Obstetrics and gynecology. 2025-03-13. PMID:40080822. |
self-reported weekly cannabis use was associated with greater odds of mild (aor 1.85, 95% ci, 1.68-2.03) and severe (aor 2.87, 95% ci, 2.47-3.34) nvp compared with individuals without prenatal use. |
2025-03-13 |
2025-03-16 |
Not clear |
| Francisco Madrid-Gambin, Noemí Haro, Natasha L Mason, Pablo Mallaroni, Eef L Theunissen, Stefan W Toennes, Oscar J Pozo, Johannes G Ramaeker. Metabolomic profiling of cannabis use and cannabis intoxication in humans. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2025-03-13. PMID:40074870. |
a total of 14 metabolites, mainly related to endocannabinoid and amino acid metabolism, were identified that distinguished chronic from occasional cannabis users and that yielded a discriminant analysis model with an 80% classification rate (95% ci: 61-91%). |
2025-03-13 |
2025-03-15 |
Not clear |
| Lee D Mulligan, Filippo Varese, Kamelia Harris, Gillian Haddoc. Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies. Psychological medicine. vol 55. 2025-03-10. PMID:40059733. |
cannabis use was not associated with odds of suicide death or suicidal ideation but was associated with risks of suicide death (hr = 1.21, 95% ci = 1.04 - 1.40) and odds of attempted suicide (or = 1.40, 95% ci = 1.16 - 1.68). |
2025-03-10 |
2025-03-12 |
Not clear |
| Wayne Kepner, Kevin H Yang, Patricia Dionicio, Katie Bailey, Nora Satybaldiyeva, Alison Moore, Benjamin H Han, Joseph J Palama. Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020. Journal of psychoactive drugs. 2025-03-03. PMID:40033160. |
lifetime use of other substances including cannabis (aor = 28.4, 95% ci: 17.1-47.2), ketamine (aor = 10.9, 95% ci: 1.63-73.4), lsd (aor = 3.82, 95% ci: 1.98-7.37), cocaine (aor = 3.77, 95% ci: 2.54-5.59), psilocybin (aor = 3.29, 95% ci: 1.75-6.16), prescription opioids (aor = 2.43, 95% ci: 1.44-4.09), and prescription stimulants (aor = 1.96, 95% ci: 1.29-2.99) were associated with increased odds of ecstasy/mdma use. |
2025-03-03 |
2025-03-06 |
Not clear |
| Bernard Weigel, Jay Manadan, Neil Manadan, Mark B Mycy. Hospitalization for carbon monoxide poisoning is associated with substance use and mood disorders. Internal and emergency medicine. 2025-01-17. PMID:39821180. |
in multivariable analysis, male sex (or 1.98; 95% ci 1.83-2.15), alcohol use disorder (or 1.89; 95% ci 1.71-2.10), cannabis use disorder (or 1.26; 95% ci 1.09-1.47), mood disorders (or 2.65; 95% ci 2.44-2.88), and suicide ideation (or 1.74; 95% ci 1.50-2.02) were independently associated with hospitalization. |
2025-01-17 |
2025-01-20 |
Not clear |
| Mobolanle Balogun, Lisa M Kuhns, Alani S Akanmu, Robert Garofalo, Titilope Badru, Abiodun F Adekanmbi, Akinsegun Akinbami, Oche Agbaji, Agatha N David, Olayinka Omigbodun, Marbella Cevantes, Patrick Janulis, Patricia Akintan, Olutosin Awolude, Kehinde M Kuti, Oluwajimi Sodipo, Esther Yiltok, Gbenayon J Mautin, Priscilla Ezemelue, Baiba Berzins, Babafemi Taiw. Risk Factors for Viral Non-suppression Among Youth Living with HIV in Nigeria: Findings from the iCARE Nigeria Study. AIDS and behavior. 2024-12-09. PMID:39652275. |
in the final model, substance use (other than alcohol, tobacco and/or cannabis) (aor = 3.20 [95% ci: 1.05, 10.34]), missed medication doses (aor = 1.09 [95% ci: 1.04, 1.15]), and a higher number of self-reported medication barriers (e.g., forgot, busy, change in routine) (aor = 1.08 [95% ci: 1.00, 1.16]) were associated with a higher likelihood of viral non-suppression. |
2024-12-09 |
2024-12-12 |
human |
| Ellicott C Matthay, Rafael Charris, Jennifer Ahern, Dorie E Apollonio, Victoria Jent, Laurie M Jacobs, Shelley Jung, Laura A Schmidt, Paul Gruenewal. Interactive associations of cannabis and alcohol outlet densities with assault injuries in California: A spatiotemporal analysis. American journal of epidemiology. 2024-10-03. PMID:39358994. |
if recreational cannabis outlets were never introduced, we estimated that nonfirearm assault injuries would have been 1.63 per 100,000 lower (95%ci: -3.08, 0.01) but we observed no association with firearm assault injuries (rd per 100,000: -0.07; 95%ci: -0.34, 0.21). |
2024-10-03 |
2024-10-05 |
Not clear |
| Amrit Baral, Bria-Necole A Diggs, Anurag Aka, Renessa Williams, Nicholas Hernandez Ortega, Ranya Marrakchi El Fellah, Jessica Y Islam, Marlene Camacho-Rivera, Frank J Penedo, Denise C Vido. Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center. Journal of cancer education : the official journal of the American Association for Cancer Education. 2024-09-18. PMID:39294413. |
logistic regression showed newly diagnosed patients had lower odds (aor, 0.41; 95% ci, 0.12-0.98) of comfort discussing cannabis compared to those in follow-up/finished treatment. |
2024-09-18 |
2024-09-21 |
Not clear |
| Amrit Baral, Bria-Necole A Diggs, Anurag Aka, Renessa Williams, Nicholas Hernandez Ortega, Ranya Marrakchi El Fellah, Jessica Y Islam, Marlene Camacho-Rivera, Frank J Penedo, Denise C Vido. Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center. Journal of cancer education : the official journal of the American Association for Cancer Education. 2024-09-18. PMID:39294413. |
younger patients (20-39 years) also had lower odds (aor, 0.11; 95% ci, 0.03-0.40) of feeling comfortable discussing cannabis compared to older patients (≥ 60 years). |
2024-09-18 |
2024-09-21 |
Not clear |
| Kelly C Young-Wolff, Felicia W Chi, Gwen T Lapham, Stacey E Alexeeff, Monique B Does, Deborah Ansley, Cynthia I Campbel. Changes in Prenatal Cannabis Use Among Pregnant Individuals From 2012 to 2022. Obstetrics and gynecology. 2024-08-29. PMID:39208448. |
the prevalence of prenatal cannabis use increased from 5.5% (95% ci, 5.3-5.8%) in 2012 to 9.0% (95% ci, 8.7-9.2%) in 2022 (adjusted prevalence ratio [apr] 1.82, 95% ci, 1.72-1.92), with similar increases by toxicology test (apr 1.70, 95% ci, 1.60-1.81) and self-report (apr 2.12, 95% ci, 1.95-2.30). |
2024-08-29 |
2024-09-04 |
Not clear |
| Zachary D Zuschlag, Benjamin Lord, Teagen Smith, Alexander Lengerich, Brianna Tindall, Kaitlin Leonard, Yvette Guereca, Vanessa Panaite, Ambuj Kumar, Michael A Norred, Vanessa A Milso. The Management of Depression and Anxiety in Primary Care: Examining Predictors of Adherence to a Psychopharmacological Collaborative Care Management Program for Veterans. The journal of behavioral health services & research. 2024-08-23. PMID:39179923. |
after controlling for baseline differences, age remained a significant positive predictor of completion (or 1.019, 95% ci 1.008‒1.030) and cannabis use a significant negative predictor (or 0.507, 95% ci 0.275‒0.934). |
2024-08-23 |
2024-08-27 |
Not clear |
| Dana Rubenstein, Michael J Green, Maggie M Sweitzer, Francis J Keefe, F Joseph McClerno. Bidirectional relationships between pain and patterns of cannabis and tobacco use in a US nationally representative sample. Pain. 2024-08-22. PMID:39172858. |
compared with no cannabis/tobacco use at t1, co-use (or: 2.29 [95% ci: 2.09-2.51]), exclusive tobacco use (2.00 [1.86-2.14]), and exclusive cannabis use (1.35 [1.13-1.61]) were all associated with moderate/severe pain at t2. |
2024-08-22 |
2024-08-25 |
Not clear |
| Stephanie Zellers, Jenny van Dongen, Hermine H M Maes, Miina Ollikainen, Fang Fang, Scott Vrieze, Jaakko Kaprio, Dorret I Boomsm. A Bivariate Twin Study of Lifetime cannabis Initiation and Lifetime Regular Tobacco Smoking Across Three Different Countries. Behavior genetics. 2024-07-30. PMID:39078541. |
data from the netherlands twin register, finntwin12/16, and the minnesota center for twin family research (total n = 21,617) were analyzed in bivariate threshold models of lifetime regular smoking initiation (rsi) and lifetime cannabis initiation (ci). |
2024-07-30 |
2024-08-02 |
Not clear |
| Giovany Oliveira Costa, Vanessa K Ota, Matheus Rodrigues Luiz, Joice Santos Rosa, Gabriela Xavier, Jessica Honorato Mauer, Marcos L Santoro, Carolina Muniz Carvalho, Daniel A Cavalcante, Amanda V G Bugiga, Rodrigo A Bressan, Gerome Breen, Ary Gadelha, Cristiano Noto, Diego R Mazzotti, Sintia I Belanger. A hybrid model for predicting response to risperidone after first episode of psychosis. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2024-07-29. PMID:39074074. |
the hybrid model, which included duration of untreated psychosis, clinical global impression-severity scale scores, age, cannabis use, and 406 snvs, showed the best performance (balanced accuracy: 72.9% [ci 0.62-0.84] - rf algorithm). |
2024-07-29 |
2024-08-02 |
Not clear |
| Bijan Pirnia, Ali Soleimani, Ali Farhoudian, Alireza Zahiroddi. Prediction of suicidal thoughts and behaviors based on the diurnal cortisol pattern and THC dosage in continued cannabis users, a 5 year population-based matched cohort study. Psychiatry research. vol 339. 2024-07-28. PMID:39068898. |
the analysis showed that the likelihood of stb in individuals with a cortisol awakening response (car) and a blunted diurnal cortisol slope (dcs) and higher area under the curve (auc) who reported heavy cannabis use was more than three times higher than the control group (or 3.2, 95 % ci 2.4-4.1). |
2024-07-28 |
2024-08-02 |
Not clear |
| Rúbia Maria Weffort de Oliveira, Nathalia Akemi Kohara, Humberto Milan. Cannabidiol in experimental cerebral ischemia. International review of neurobiology. vol 177. 2024-07-19. PMID:39029992. |
cannabidiol (cbd), the most abundant non-psychotomimetic compound derived from cannabis sativa, is a pleiotropic substance that interacts with diverse molecular targets and has the potential to influence various pathophysiological processes, thereby contributing to enhanced outcomes in ci. |
2024-07-19 |
2024-07-22 |
Not clear |
| Rahul K Chaliparambil, Mehul Mittal, William Gibson, Christopher Ahuja, Nader S Dahdaleh, Najib El Tecl. Association Between Preoperative Cannabis Use and Increased Rate of Revision Surgery Following Spinal Fusion: A Systematic Review and Meta-Analysis. Cureus. vol 16. issue 6. 2024-07-08. PMID:38975423. |
the rate of revision surgery among cannabis users was higher than that in non-users for all spinal fusions (rr: 3.58, 95% ci: 1.67 to 7.66, p = 0.001). |
2024-07-08 |
2024-07-11 |
Not clear |